Beta-Amyrin

Beta-Amyrin

SCHEMBL377754

CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 1.00
ALOX5 P09917 4/20 0.79
CES1 P23141 3/20 0.77
CES2 O00748 1/20 0.77
PTPN1 P18031 9/20 0.77
AKR1B10 O60218 3/20 0.77
AKR1B1 P15121 1/20 0.77
POLB P06746 3/20 0.76
PTPN2 P17706 3/20 0.76
PSMB11 A5LHX3 2/20 0.76
PSMA7 O14818 2/20 0.76
PLA2G1B P04054 2/20 0.76
PTPRC P08575 2/20 0.76
PTPRF P10586 2/20 0.76
F3 P13726 2/20 0.76
PSMB1 P20618 2/20 0.76
ACP1 P24666 2/20 0.76
PSMA1 P25786 2/20 0.76
PSMA2 P25787 2/20 0.76
PSMA3 P25788 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beta-Amyrin SCHEMBL1696465 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL17124229 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL3119711 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL1696463 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL14226156 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL14828378 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL18376076 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL18687837 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL12313094 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1
Beta-Amyrin SCHEMBL2025280 1.00 USP2 (1.00) USP2ALOX5CES1CES2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2485 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731172-A2 COSMETIC COMPOSITION COMPRISING AT LEAST ONE NATURAL RESIN AND A CRYSTALLIZABLE FATTY SUBSTANCE L'OREAL (FR) 2026-04-29 EP claimed
US-20260027136-A1 CANNABIS BASED THERAPEUTIC AND METHOD OF USE YUZU LV LLC (US) 2026-01-29 US claimed
US-20250262228-A1 TREATMENT OF SPASTICITY AND PAIN IN RENALLY-IMPAIRED PATIENTS U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE 2025-08-21 US claimed
CN-120035431-A Cosmetic composition comprising natural resin 莱雅公司 2025-05-23 CN claimed
EP-4551300-A1 COSMETIC COMPOSITION COMPRISING A NATURAL RESIN L'OREAL (FR) 2025-05-14 EP claimed
EP-4552652-A2 TERPENE-ENRICHED CANNABINOID COMPOSITION Buzzelet Development And Technologies Ltd (IL) 2025-05-14 EP claimed
EP-3429580-B1 TERPENE-ENRICHED CANNABINOID COMPOSITION BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) 2025-05-07 EP claimed
CN-119846158-A Camellia oil adulteration identification method and system 江西省检验检测认证总院食品检验检测研究院(江西省粮食质量检验中心) 2025-04-18 CN claimed
CN-115074399-B Loquat triterpenic acid synthesis key enzyme gene EjCYP A1/2 and EjCYP716C1/2 and application 华南农业大学 2025-04-04 CN claimed
CN-119709712-A Dammarenediol synthase mutant and application thereof in preparation of beta-amyrin alcohol 云南农业大学 2025-03-28 CN claimed
WO-2002055639-A1 A PROCESS FOR THE PREPARATION OF A FAT COMPOSITION CONTAINING STEROL ESTERS A PRODUCT OBTAINED BY SAID PROCESS AND THE USE THEREOF KARLSHAMNS AB (SE) 2002-07-18 WO claimed
EP-1200106-A1 COMPOSITION CONTAINING EXTRACTS OF BUTYROSPERMUM PARKII AND THE USE AS MEDICAMENT OR DIETARY SUPPLEMENT Astion Development APS (DK) 2002-05-02 EP claimed
WO-2001066773-A2 NUCLEIC ACIDS THAT CODE FOR OXIDOSQUALENE CYCLASES E.I. DUPONT DE NEMOURS AND COMPANY (US) 2001-09-13 WO claimed
WO-2001046391-A2 PLANT GENE PLANT BIOSCIENCE LIMITED (GB) 2001-06-28 WO claimed
WO-2001003712-A1 COMPOSITION CONTAINING EXTRACTS OF BUTYROSPERMUM PARKII AND THE USE AS MEDICAMENT OR DIETARY SUPPLEMENT ASTION DEVELOPMENT APS (DK) 2001-01-18 WO claimed
WO-2000072862-A1 CRANBERRY SEED OIL EXTRACT AND COMPOSITIONS CONTAINING COMPONENTS THEREOF OCEAN SPRAY CRANBERRIES, INC. (US) 2000-12-07 WO claimed
US-6063383-A Pharmaceutical suppository composites for fever and influenza and method of producing the composites HSU WU-CHING (TW) 2000-05-16 US claimed
US-5679354-A VACCINE HAVING AN ISCOM-LIKE STRUCTURE COMPRISING AT LEAST ONE LIPID AND ONE SAPONIN AND BEING FREE OF INCORPORATED ANTIGENS MOREIN BROR (SE) 1997-10-21 US claimed
CN-1048925-A Producing with detection agent (the affinity thing of cholesterol) and visual developer serves as that the basis is used for method and this application of compound at the affinity enzyme compound of the visual demonstration cholesterol of patient skin surface NII FIZ KHIM MEDITSINY (SU) 1991-01-30 CN claimed
US-4220588-A PREPARATION OF ALPHA, BETA-UNSATURATED ALDEHYDE OR KETONE BY DEHYOROGENATING WITH ARYLSELENINIC ANHYDRIDE RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC., 49 AMHERST ST., CAMBRIDGE, MA. 02142, 1980-09-02 US claimed